Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Very Good News!

<< Previous

Bullboard Posts

Next >>

Comment by DeathXray33on Dec 18, 2022 8:29am

220 Views

Post# 35178269

RE:RE:RE:RE:RE:RE:Very Good News!

ScienceFirst wrote:

https://www.fiercepharma.com/pharma/after-2020-rejection-ferring-finally-nabs-fda-nod-bladder-cancer-gene-therapy

Since then, Ferring has been working with its partner and the FDA to bring the production process in line with the agency’s expectations, Metzger said. As with other gene therapies, Adstiladrin has a “very complicated, very long, very product-tailored" production process, he noted.

The company is working with a Finnish manufacturing partner called FinVector. At the same time, Ferring is also working to grow its own capacity, Metzger said.

I have no worries & let the #'s calm us...